These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14713135)

  • 1. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
    Sofuoglu M; Gonzalez G; Poling J; Kosten TR
    Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
    Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
    Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
    Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients.
    Kosten T; Poling J; Oliveto A
    Addiction; 2003 May; 98(5):665-71. PubMed ID: 12751984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
    Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ
    Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response.
    Kosten T; Sofuoglu M; Poling J; Gonsai K; Oliveto A
    Am J Addict; 2005; 14(1):8-17. PubMed ID: 15804873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone.
    Kosten T; Falcioni J; Oliveto A; Feingold A
    Am J Addict; 2004; 13(2):191-201. PubMed ID: 15204669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
    Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
    J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone and buprenorphine combination in the treatment of opioid dependence.
    Gerra G; Fantoma A; Zaimovic A
    J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.
    Bagley SM; Cheng DM; Winter M; Alford DP; LaBelle C; Walley AY; Samet JH
    Drug Alcohol Depend; 2018 Nov; 192():245-249. PubMed ID: 30290291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
    Feingold A; Oliveto A; Schottenfeld R; Kosten TR
    Am J Addict; 2002; 11(2):111-23. PubMed ID: 12028741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of psychotherapy attendance on buprenorphine treatment outcome.
    Montoya ID; Schroeder JR; Preston KL; Covi L; Umbricht A; Contoreggi C; Fudala PJ; Johnson RE; Gorelick DA
    J Subst Abuse Treat; 2005 Apr; 28(3):247-54. PubMed ID: 15857725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients.
    Campbell J; Nickel EJ; Penick EC; Wallace D; Gabrielli WF; Rowe C; Liskow B; Powell BJ; Thomas HM
    Am J Addict; 2003; 12(2):122-36. PubMed ID: 12746087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
    Schottenfeld RS; Chawarski MC; Cubells JF; George TP; Lappalainen J; Kosten TR
    Drug Alcohol Depend; 2014 Mar; 136():36-42. PubMed ID: 24462581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.
    Sullivan LE; Moore BA; O'Connor PG; Barry DT; Chawarski MC; Schottenfeld RS; Fiellin DA
    Am J Addict; 2010; 19(1):53-8. PubMed ID: 20132122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.
    George TP; Chawarski MC; Pakes J; Carroll KM; Kosten TR; Schottenfeld RS
    Biol Psychiatry; 2000 Jun; 47(12):1080-6. PubMed ID: 10862808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.
    Chopra MP; Landes RD; Gatchalian KM; Jackson LC; Buchhalter AR; Stitzer ML; Marsch LA; Bickel WK
    Exp Clin Psychopharmacol; 2009 Aug; 17(4):226-36. PubMed ID: 19653788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.